These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23251215)

  • 1. Familial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects.
    Bu F; Borsa N; Gianluigi A; Smith RJ
    Clin Dev Immunol; 2012; 2012():370426. PubMed ID: 23251215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical hemolytic uremic syndrome.
    Loirat C; Frémeaux-Bacchi V
    Orphanet J Rare Dis; 2011 Sep; 6():60. PubMed ID: 21902819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.
    Bu F; Maga T; Meyer NC; Wang K; Thomas CP; Nester CM; Smith RJ
    J Am Soc Nephrol; 2014 Jan; 25(1):55-64. PubMed ID: 24029428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.
    Noris M; Caprioli J; Bresin E; Mossali C; Pianetti G; Gamba S; Daina E; Fenili C; Castelletti F; Sorosina A; Piras R; Donadelli R; Maranta R; van der Meer I; Conway EM; Zipfel PF; Goodship TH; Remuzzi G
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1844-59. PubMed ID: 20595690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement disorders and hemolytic uremic syndrome.
    Joseph C; Gattineni J
    Curr Opin Pediatr; 2013 Apr; 25(2):209-15. PubMed ID: 23399570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical hemolytic uremic syndrome.
    Kavanagh D; Goodship TH; Richards A
    Semin Nephrol; 2013 Nov; 33(6):508-30. PubMed ID: 24161037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
    Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP
    Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and complement in atypical HUS.
    Kavanagh D; Goodship T
    Pediatr Nephrol; 2010 Dec; 25(12):2431-42. PubMed ID: 20526633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult Post-Kidney Transplant Familial Atypical Hemolytic Uremic Syndrome Successfully Treated With Eculizumab: A Case Report and Literature Review.
    Salameh H; Abu Omar M; Alhariri A; Kisra S; Qasem A; Abdulhak AB
    Am J Ther; 2016; 23(4):e1110-5. PubMed ID: 25486517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement therapy in atypical haemolytic uraemic syndrome (aHUS).
    Wong EK; Goodship TH; Kavanagh D
    Mol Immunol; 2013 Dec; 56(3):199-212. PubMed ID: 23810412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttransplant recurrence of atypical hemolytic uremic syndrome.
    Valoti E; Alberti M; Noris M
    J Nephrol; 2012; 25(6):911-7. PubMed ID: 22760880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.
    Provaznikova D; Rittich S; Malina M; Seeman T; Marinov I; Riedl M; Hrachovinova I
    Pediatr Nephrol; 2012 Jan; 27(1):73-81. PubMed ID: 21706448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.
    Kavanagh D; Goodship TH
    Hematology Am Soc Hematol Educ Program; 2011; 2011():15-20. PubMed ID: 22160007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement regulatory genes and hemolytic uremic syndromes.
    Kavanagh D; Richards A; Atkinson J
    Annu Rev Med; 2008; 59():293-309. PubMed ID: 17705684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab.
    Besbas N; Gulhan B; Karpman D; Topaloglu R; Duzova A; Korkmaz E; Ozaltin F
    Pediatr Nephrol; 2013 Jan; 28(1):155-8. PubMed ID: 22956028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
    Maga TK; Nishimura CJ; Weaver AE; Frees KL; Smith RJ
    Hum Mutat; 2010 Jun; 31(6):E1445-60. PubMed ID: 20513133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of atypical hemolytic uremic syndrome (aHUS).
    Rodríguez de Córdoba S; Hidalgo MS; Pinto S; Tortajada A
    Semin Thromb Hemost; 2014 Jun; 40(4):422-30. PubMed ID: 24799305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy.
    Fakhouri F; Frémeaux-Bacchi V; Loirat C
    Eur J Intern Med; 2013 Sep; 24(6):492-5. PubMed ID: 23756030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical hemolytic uremic syndrome: update on the complement system and what is new.
    Hirt-Minkowski P; Dickenmann M; Schifferli JA
    Nephron Clin Pract; 2010; 114(4):c219-35. PubMed ID: 20090363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.